Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention.
about
Khat use and neurobehavioral functions: suggestions for future studiesThe neural bases of obsessive-compulsive disorder in children and adultsMirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: evidence from the bench and the bedsideModulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addictionExtinction of drug- and withdrawal-paired cues in animal models: relevance to the treatment of addiction.Predicting treatment outcome in stimulant dependenceTract-Based Spatial Statistics (TBSS) of diffusion tensor imaging data in alcohol dependence: abnormalities of the motivational neurocircuitry.Imaginal desensitisation plus motivational interviewing for pathological gambling: randomised controlled trialStructural MRI findings in long-term cannabis users: what do we know?Differences in functional connectivity between alcohol dependence and internet gaming disorderImpulsivity and pathological gambling: Is it a state or a trait problem?Obsessive-compulsive disorder, impulse control disorders and drug addiction: common features and potential treatments.Hippocampal remodelling after MDMA neurotoxicity: a single case study.Optimal neurocognitive, personality and behavioral measures for assessing impulsivity in cocaine dependence.A 6-month follow-up of imaginal desensitization plus motivational interviewing in the treatment of pathological gambling.Adolescent brain development and underage drinking in the United States: identifying risks of alcohol use in college populationsDecreased frontal lobe phosphocreatine levels in methamphetamine users.Working memory and impulsivity predict marijuana-related problems among frequent users.Understanding drug addiction: a neuropsychological perspective.Neural circuitry of impulsivity in a cigarette craving paradigm.Prefrontal cortical and striatal activity to happy and fear faces in bipolar disorder is associated with comorbid substance abuse and eating disorder.Treating comorbid substance use disorders in schizophrenia.Current hypotheses on the mechanisms of alcoholism.Performance of Smokers with DSM-5 Tobacco Use Disorder in Time-Based Complex Prospective Memory.Volumetric differences in the anterior cingulate cortex prospectively predict alcohol-related problems in adolescence.Abnormal intrinsic functional hubs in alcohol dependence: evidence from a voxelwise degree centrality analysis.Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors.Time-dependent neuronal changes associated with craving in opioid dependence: an fMRI study.COMT Val158Met modulates the effect of childhood adverse experiences on the risk of alcohol dependence.Family-based association analysis of serotonin genes in pathological gambling disorder: evidence of vulnerability risk in the 5HT-2A receptor gene.Performance of cocaine dependent individuals and controls on a response inhibition task with varying levels of difficulty.Effects of unilatral- and bilateral inhibition of rostral ventral tegmental area and central nucleus of amygdala on morphine-induced place conditioning in male Wistar rat.Brain function during cognitive flexibility and white matter integrity in alcohol-dependent patients, problematic drinkers and healthy controls.Executive control among adolescent inhalant and cannabis users.Drugs, mental health and the adolescent brain: implications for early intervention.Cognitive deficits in problematic drinkers with and without mild to borderline intellectual disability.Aberrant regional brain activities in alcohol dependence: a functional magnetic resonance imaging study.Addiction-Related Cognitive Impairment in Substance Use Disorder Treatment: Behavioral Suggestions for Addictions Treatment Practitioners
P2860
Q24610235-25FEB243-4364-4CFE-933B-1761CECF5845Q24612431-7C8069B5-9922-4B77-9D6F-54134C13746DQ24622161-60E4CBF1-9895-4E8F-8E90-17D944A559D5Q27014154-D7F74685-1066-4E2C-89A0-A0CEC7B7CC92Q30478600-6B6DF642-8298-4139-B63E-9102381FE488Q33383362-5FE531A1-2FA2-466F-BB2F-121AD8A4F027Q33445780-F4F8BC4D-DE70-43FC-AEE4-00CB83907F0FQ33572092-F39E0D29-4BFF-4352-B50D-FA1284E3197CQ33621732-B604BD12-DEC7-48B6-B89C-55260B21F1D0Q33885413-BA0B26C1-C3A6-4F8A-8418-D355F4C947A6Q34073098-99705A33-D393-4000-989C-C62C21BF2123Q34184771-E0F67027-999C-4641-B967-B9C1E4D91CB5Q34593899-F7B19042-FA3C-44E8-A1FD-88C48E7E451EQ35664896-A3F6F74A-9578-4834-AAA0-FCFF76E5B44CQ36302186-2AB28D3C-F5F5-4609-939A-FC636624BA82Q36347697-633CD8FB-82FE-4AA1-894F-52814866E562Q36609285-300430EB-253B-46AD-B9E8-95A8AC779E9CQ36767176-7F612466-7258-4E6B-ACA9-877C0D7A546AQ36999794-D0611251-5997-42DB-A274-4A11AEF750A0Q37017654-0EB53B7C-8452-49EB-8DA7-6CEB90927E78Q37350387-D118403B-331F-407E-97E5-7656C06CD8B9Q37760932-4121DB7A-9469-4BDF-A7CE-1D5B24169ECFQ38259382-457C7271-F4DF-4EFE-BC1B-21D383137041Q38987951-9AD00605-7797-47FD-AEB5-8CE44058D060Q39247820-20700F92-8FE2-4C06-840F-B426AD641168Q41284025-553C793F-91AF-493A-B237-B452EB2D3ED5Q42671767-22ECDD80-4F8E-47F0-AA75-3D8970A2A99EQ44349141-5126E85B-ABD1-472E-9D48-06270E35A627Q46089166-55011D46-D85B-4432-A0F9-B937EDAFB63FQ46134034-C9578063-03C8-43A1-AF68-3A756D3815F2Q46984620-1B6D7CC3-F70B-4192-9275-6FE21DF774D4Q47351042-4ED86E86-DDA9-4E0A-9083-3ACC0FB78843Q48423112-4D45EFA3-2B44-4493-A13C-25E8E9F05C7BQ51018461-0819EE70-D4FF-4480-8567-68AD63E47FB6Q51891385-34F1560D-9EF0-46FE-9EE2-09AF8127D67CQ52310438-DF3300F7-A76F-4C09-A130-AA5B893BEDFBQ53420775-73112FE5-2DAD-4A9C-B173-479898790043Q58108525-5B3FFB76-BCF4-4D08-BD20-45780F79C3E6
P2860
Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Neurocognitive and neuroimagin ...... sis, treatment and prevention.
@ast
Neurocognitive and neuroimagin ...... sis, treatment and prevention.
@en
type
label
Neurocognitive and neuroimagin ...... sis, treatment and prevention.
@ast
Neurocognitive and neuroimagin ...... sis, treatment and prevention.
@en
prefLabel
Neurocognitive and neuroimagin ...... sis, treatment and prevention.
@ast
Neurocognitive and neuroimagin ...... sis, treatment and prevention.
@en
P1476
Neurocognitive and neuroimagin ...... sis, treatment and prevention.
@en
P356
10.1080/09595230601036978
P577
2007-01-01T00:00:00Z